Skip to content

Efficacy comparison of Allevyn Gentle Border and conventional dressing in rotator cuff repair

Efficacy of Allevyn Gentle Border dressing versus conventional wound dressing in patients with surgical wounds from rotator cuff repair: a randomized controlled non-inferiority trial

Status
Recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN97372145
Enrollment
68
Registered
2024-05-01
Start date
2024-12-01
Completion date
Unknown
Last updated
2025-01-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

To expand the range of dressing options for managing surgical wounds from rotator cuff repair Injury, Occupational Diseases, Poisoning

Interventions

This is a non-inferiority trial and cost-benefit analysis of silicone adhesive foam dressing for wound management after rotator cuff suture repair. The sample size will be 68 patients who will be rand

Sponsors

West China Hospital of Sichuan University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Age between 18 and 80 years 2. Undergoing initial rotator cuff repair 3. Surgical procedures will be performed by the same surgeon using the same surgical technique and suture materials 4. Good patient compliance and regular follow-ups are essential 5. Voluntary participation in the study with signed informed consent

Exclusion criteria

Exclusion criteria: 1. Patients with conditions that may affect wound healing, including hypertension, diabetes, hypoproteinemia, malnutrition (defined as body mass index or BMI 28 kg/m2), rheumatoid disease, tumor, connective tissue disease, hemophilia, limb vascular disease, psoriasis, radiation injury, gangrene, genetic diseases, anemia, gout, or other diseases that may affect wound healing 2. Long-term use of immunosuppressive agents, glucocorticoids, biological agents, anticoagulants, antiplatelet drugs, or no standardized adjustment and withdrawal pre-surgery 3. Long-term history of smoking or alcohol consumption 4. Preoperative history of surgery or infection at the surgical site 5. Scars, skin lesions, or rashes at the surgical site pre-surgery 6. Recent history (within 1 month) of invasive procedures, such as acupuncture, small needle knife, or drug injection at the surgical site 7. Psoriasis, eczema, dermatitis or other skin diseases 8. Allergic to any dressing components

Design outcomes

Primary

MeasureTime frame
The following primary outcome measures will be assessed using data collected from study records at 1, 2 and 4 weeks after surgery: 1. Incidence rate of wound complications 2. The cost-effectiveness of wound care, analyzed using the cost-effectiveness ratio (CER) and incremental cost-effectiveness ratio (ICER). The total direct costs related to surgical wound care will include registration fees, dressing change costs, dressing costs and the cost of management of complications

Secondary

MeasureTime frame
The following secondary outcome measures will be assessed, unless stated, using data collected from study records at 1, 2 and 4 weeks after surgery: 1. Wound healing rate 2. Healing time 3. Dressing wear time 4. Number of dressing changes 5. Clinician's evaluation of dressing performance characteristics measured using a Likert 4-point scoring method 6. Patient's evaluation of the dressing measured using a Likert 4-point scoring method

Countries

China

Contacts

Public ContactJinyu Wu
624513481@qq.com+86 17857314966

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026